This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Topical steroids in eczema

Authoring team

Topical steroids are the mainstay of eczema treatment and are used intermittently during flare-ups of the disease (1).

The treatment regimens may vary according to the severity of the disease but the mildest potency preparation is usually recommended by the clinicians for treatment (1).

When prescribing topical steroid treatment the clinician must consider:

  • strength of topical steroid
  • duration of use of topical steroid
  • vehicle used with topical steroid
  • site of eczema/dermatitis
  • age of patient

Emollients are prescribed together with topical corticosteroids (1,2,3).

SIGN state (3)

  • patients with atopic eczema should be advised to apply topical corticosteroids once daily
    • if there is an inadequate response to once daily application, the frequency should be increased to twice daily
  • twice weekly maintenance therapy with a topical corticosteroid should be considered in patients with moderate to severe atopic eczema experiencing frequent relapses (4)
  • topical corticosteroids should be used with caution in the periocular region

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.